TrialBritish journal of cancer2004

Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer.

W Ichikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.